Ria Biosciences Private Limited
About Ria Biosciences Private Limited
Data last updated:
Ria Biosciences Private Limited is a private limited company based in Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 01 September 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24309DL2022PTC404014. Its GSTIN is 05AAMCR1460Q1ZW (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sakshi Juneja and Rakesh Bansal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 6 3rd Floor Avtar Enclave Paschim Vihar, Delhi, India – 110063.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.34 Cr, a growth of 66% compared to the previous year. For the same year it recorded a net profit of ₹8.93 Lakh (net margin 1.1%) and EBITDA of ₹38.12 Lakh (EBITDA margin 4.6%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ria Biosciences Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 6 3rd Floor Avtar Enclave Paschim Vihar, Delhi, India – 110063
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Ria Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ria Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ria Biosciences Private Limited, buy the company report.
Financials of Ria Biosciences Private Limited
FY 2024 filings availableRia Biosciences Private Limited reported revenue of ₹8.34 Cr (up 66% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 66% in the latest year. EBITDA rose 200% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹38.12 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹8.93 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 4.6% | ||
| Net Profit Margin | 1.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Ria Biosciences Private Limited, buy the company report.
Board of directors of Ria Biosciences Private Limited
Ria Biosciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sakshi Juneja Also directs: Waves Bio-Tech Pvt Ltd | Director | 01 Sep 2022 | 4 Years 2 Months | Current |
| Rakesh Bansal | Director | 01 Sep 2022 | 4 Years 2 Months | Current |
Peer comparison
Ria Biosciences Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Biosciences, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pasteur Laboratories Pvt Ltd | ₹8.36 Cr (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Joshika Pharma Private Limited | ₹8.35 Cr (FY 2023) | -56.0% | Hyderabad, Telangana, India | |||
| Ria Biosciences Private Limitedthis company | ₹8.34 Cr (FY 2025) | ₹8.93 Lakh | 1.1% | 66.0% | Delhi, India | |
| Sterlife Biotech Private Limited | ₹8.32 Cr (FY 2025) | 17.0% | Ahmedabad, Gujarat, India | |||
| Almet Lifesciences Private Limited | ₹8.32 Cr (FY 2025) | 2.0% | Ahmedabad, Gujarat, India | |||
| Issar Pharmaceuticals Private Limited | ₹8.31 Cr (FY 2024) | Hyderabad, Telangana, India |
To see the full peer comparison of Ria Biosciences Private Limited, buy the company report.
Auditor
Ria Biosciences Private Limited is audited by V.K. KHOSLA & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.K. KHOSLA & CO | FY 2024 | 02283N |
Shareholding
The shareholding of Ria Biosciences Private Limited is on record for 2 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ria Biosciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ria Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ria Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ria Biosciences Private Limited has 1 active EPFO establishment as of Mar 21, 2025.
GST
Ria Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAMCR1460Q1ZW | Uttarakhand | Active | 28 Oct 2022 |
To see the full GST registrations and return filing status of Ria Biosciences Private Limited, buy the company report.
Recent activity
Ria Biosciences Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Rakesh Bansal was appointed as Director on 01 Sep 2022.
Frequently asked questions
Ria Biosciences is an active private limited company based in Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 01 September 2022 (4+ years old) and is registered under CIN U24309DL2022PTC404014.
Ria Biosciences has 2 current directors:
- Sakshi Juneja - Director
- Rakesh Bansal - Director
The latest financial statements of Ria Biosciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Ria Biosciences is 05AAMCR1460Q1ZW, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Ria Biosciences is U24309DL2022PTC404014. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ria Biosciences was incorporated on 01 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ria Biosciences by revenue are Pasteur Laboratories Pvt Ltd, Joshika Pharma Private Limited, Sterlife Biotech Private Limited, Almet Lifesciences Private Limited, Issar Pharmaceuticals Private Limited, all in the Pharma industry (Biosciences, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rakesh Bansal was appointed as Director on 01 Sep 2022. Sakshi Juneja was appointed as Director on 01 Sep 2022.
The registered office of Ria Biosciences is at Plot No 6 3rd Floor Avtar Enclave Paschim Vihar, Delhi, India – 110063.
Ria Biosciences operates in the chemicals industry, in the chemical products segment.
The compliance status of Ria Biosciences is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
